Literature DB >> 221614

Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.

J M Chapdelaine, F Plata, F Lilly.   

Abstract

Leukocyte fractions extracted from the tumor mass and the lymphoid organs of C57BL/6 (B6) mice carrying murine sarcoma virus-induced tumors contained primed cytolytic T-lymphocyte (CTL) precursor cells, in addition to active cytotoxic T cells. These leukocyte fractions gave a secondary response when stimulated in vitro with syngeneic tumor cells, generating large numbers of specific CTL. The activity of these CTL (H-2b) was apparently H-2-restricted, because it was ineffective on tumor targets bearing strongly cross-reacting tumor-specific antigens but with the H-2d haplotype. Furthermore, only H-2b cells bearing the Friend, Moloney, Rauscher-associated antigen, such as Rauscher leukemia virus-induced RBL-5 cells and Friend leukemia virus-induced HFL/b cells, were lysed efficiently. B male GV cells (H-2b cells induced by Gross leukemia virus) were not affected by the same CTL. We propose the existence of a dynamic state involving the migration of primed CTL precursor cells between the lymphoid organs and the tumor mass, as well as the differentiation of these precursor cells within the tumor mass into highly specific CTL.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221614      PMCID: PMC2184884          DOI: 10.1084/jem.149.6.1531

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Fate of H2-activated T lymphocytes in syngeneic hosts. III. Differentiation into long-lived recirculating memory cells.

Authors:  J Sprent; J F Miller
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

2.  Tumor infiltrating lymphocytes.

Authors:  E Klein; S Becker; E Svedmyr; M Jondal; F Vánky
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.

Authors:  F Plata; E Gomard; J C Leclerc; J P Levy
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

4.  Immunoglobulin and theta-bearing murine leukemias and lymphomas.

Authors:  E M Shevach; J D Stobo; I Green
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

5.  Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo.

Authors:  F Plata; B Sordat
Journal:  Int J Cancer       Date:  1977-02-15       Impact factor: 7.396

6.  In situ cytotoxic T cells in a methylcholanthrene-induced tumor.

Authors:  F DeLustro; J S Haskill
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.

Authors:  G Y Gillespie; C B Hansen; R G Hoskins; S W Russell
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

8.  In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors.

Authors:  B A Blazer; G H Heppner
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

9.  Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.

Authors:  F Plata; J C Cerottini; K T Brunner
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

10.  Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.

Authors:  F Plata; V Jongeneel; J C Cerottini; K T Brunner
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

View more
  7 in total

1.  Use of hybridoma-resident variant cell lines to study H-2Db/FMR-specific cytotoxic T cells.

Authors:  J M Chapdelaine; T V Rajan; S G Nathenson; F Lilly
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  T cells discriminate between Ia antigens expressed on allogeneic accessory cells and B cells: a potential function for carbohydrate side chains on Ia molecules.

Authors:  C Cowing; J M Chapdelaine
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

3.  Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells.

Authors:  A F Tilkin; N Schaaf-Lafontaine; A Van Acker; M Boccadoro; J Urbain
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

4.  Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo.

Authors:  D H Lynch; R E Miller
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

5.  Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors.

Authors:  K T Brunner; H R MacDonald; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

6.  Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

7.  In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.

Authors:  S Becker; S Haskill
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.